Keyphrases
Nonhuman Primate
100%
Glanders
100%
Gold Nanoparticles
100%
Glycoconjugate Vaccines
100%
Survivors
33%
Malleus
33%
Vaccination
16%
Vaccine Antigen
16%
Biothreat Agents
16%
In(III)
16%
Inhalational
16%
Vaccine Strategy
16%
Rhesus Macaque
16%
Serum IgE
16%
Causative Agents
16%
Nave
16%
Gram-negative
16%
Unvaccinated
16%
Protective Properties
16%
Multiple Organs
16%
Nanoparticles
16%
IgG Titer
16%
Survival Benefit
16%
Burkholderia Mallei
16%
FliC
16%
Aerosol Challenge
16%
Macaca mulatta
16%
Post-challenge
16%
Challenge Dose
16%
Glycoconjugates
16%
Zoonotic Pathogens
16%
Aerosol Model
16%
Burkholderia Thailandensis
16%
Pharmacology, Toxicology and Pharmaceutical Science
Glanders
100%
Gold Nanoparticle
100%
Glycoconjugate
100%
Rhesus Monkey
33%
Disease
16%
Infectious Agent
16%
Preclinical Study
16%
Nanoparticle
16%
Burkholderia mallei
16%
Burkholderia thailandensis
16%
Immunology and Microbiology
Glycoconjugate
100%
Rhesus Monkey
66%
Infectious Agent
33%
Titer
33%
Preclinical Study
33%
Zoonotic
33%
Burkholderia mallei
33%
Burkholderia thailandensis
33%